Therapeutic Areas
Coagulation/DVT – Heparin - $4 billion market
Diabetes – Insulin - $6 billion market
Osteoporosis – Calcitonin, PTH - $6 billion market
Growth Disorders – Hgh - $2 billion market
Osteoarthritis – Calcitonin - $2+ billion market
Obesity – GLP-1, rhGH, and PYY